6-Shogaol inhibits monosodium urate crystal-induced inflammation - An in vivo and in vitro study

Food and Chemical Toxicology

Volumn 48, Issue 1, 2010, Pages 229-235

  Sabina, Evan Prince ^a   Rasool, MahaboobKhan ^a   Mathew, Lazar ^a   EzilRani, Panneerselvam ^a   Indu, Haridas ^a  

^a VIT UNIVERSITY   (India)

Author keywords

6 Shogaol; Gouty arthritis; Indomethacin; Lysosomal enzymes; Polymorphonuclear leucocytes

Indexed keywords

6 SHOGAOL; ANTIOXIDANT; BETA GLUCURONIDASE; INDOMETACIN; LACTATE DEHYDROGENASE; LIPID; LYSOSOME ENZYME; PLANT MEDICINAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GINGER; GOUT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PAW EDEMA; PROTEIN BLOOD LEVEL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CATECHOLS; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FEMALE; GINGER; INDOMETHACIN; INFLAMMATION; LIVER; LYSOSOMES; MALE; MICE; NEUTROPHILS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; URIC ACID;

MUS; ZINGIBER OFFICINALE;

EID: 72149102980     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.10.005     Document Type: Article

References (38)

1. Arkene S.A.L., Simon O., Shelly J., and Gardener M. 6-Shogaol reduced chronic inflammatory response in calcium pyro phosphate dihydrate crystals. J. Exp. Med. 133 (2006) 100
2. Campion E.W., Glynn R.J., and Delabry L.O. Symptomatic hyperuricemia. Risks and consequences in the normative aging study. Am. J. Med. 82 (1987) 421-426
3. Di Giovine F.S., Malawista S.E., Thornton E., and Duff G.W. Urate crystals stimulate production of tumour necrosis factor alpha from human blood monocytes and synovial cless: cytokine mRNA and protein kinetics, and cellular distribution. J. Clin. Invest. 87 (1991) 175-181
4. Flynn D.L., Rafferty M.F., and Boctor A.M. Inhibition of human neutrophil 5-lipooxygenase activity by gingerdione, shogaol, capsaicin and related pungent compounds. Prostanglandins Leukot. Med. 24 (1968) 195-198
5. Gallin J.I. The neutrophil. In: Samber M., Talmage D.W., Frank M.M., Austen K.F., and Claman H.N. (Eds). Immunological Diseases (1988), Little Brown Co., Boston, MA 737-788
6. Govindarajan V.S. Ginger-chemistry, technology and quality evaluation: part 1. CRC Crit. Rev. Sci. Nutr. 17 (1982) 1-96
7. Grzanna R., Phan P., Polotsky A., Lindmark L., and Frondoza C.G. Ginger extract inhibits beta-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J. Altern. Complem. Med. 10 (2004) 1009-1013
8. Grzanna R., Phan P., Polotsky A., Lindmark L., and Frondoza C.G. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J. Med. Food 8 (2005) 125-132
9. Gupta O.P., Sharma N., and Chand D.A. Sensitive and selective model for evaluating anti-inflammatory activity-papaya latex-induced rat paw inflammation. J. Pharmacol. Toxicol. Meth. 28 1 (1992) 15-19
10. Hogberg J., Larson R.E., Kristoferson A., and Orrenius S. NADPH-dependent reductase solubilised from microsomes of peroxidation and its activity. Biochem. Biophys. Res. Commun. 56 (1974) 836-842
11. Kawai Y., and Anno K. Mucopolysaccharide-degrading enzymes from the liver of the squad, Ommastrephes slonaipacificus. I. Hyaluronidase. Biochim. Biophys. Acta 242 (1971) 428-436
12. King J. The dehydrogenase or oxidoreductase-lactate dehydrogenase. In: Van D. (Ed). Practical Clinical Enzymology (1965), Nostrand, London 83-93
13. King J. The hydrolases-acid and alkaline phosphatases. In: Van D. (Ed). Practical Clinical Enzymology (1965), Nostrand Company Limited, London 191-208
14. Landis R.C., and Haskard D.O. Pathogenesis of crystal-induced inflammation. Curr. Rheumatol. Rep. 3 (2001) 36-41
15. Ledwozyw A., Michalak J., Stepien A., and Kadziolka A. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin. Chim. Acta 155 (1986) 275-284
16. Liu Bryan R., and Terkeltaub R. Evil humors take their toll as innate immunity makes gouty joints trem-ble. Arthritis Rheum. 54 (2006) 383-386
17. Lowry O.H., Rosebrough N.J., Farr A.I., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
18. Marhun D. Rapid colorimetric assay of β-galactosidase and N-acetyl-β-galactosaminidase in human urine. Clin. Chim. Acta 73 (1976) 453-461
19. Marklund S.L., and Marklund G. Involvement of superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47 (1974) 469-474
20. Mustafa T., and Srivastava K.C. Possible leads for arachidonic acid metabolism altering drugs from natural products. J. Drug Dev. 3 (1990) 47-60
21. Pan M.H., Hsieh M.C., Hsu P.C., Ho S.Y., Lai C.S., and Wu H. 6-Shogaol suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. Mol. Nutr. Food Res. 52 12 (2008) 1467-1477
22. Phan P.V., Sohrabi A., Polotsky A., Hungerford D.S., Lindmark L., and Frondoza C.G. Ginger extract components suppress induction of chemokine expression in human synoviocytes. J. Altern. Complem. Med. 11 (2005) 149-154
23. Ramprasad V.R., Shanthi P., and Sachdanandam P. Evaluation of antioxidant effect of Semecarpus anacardium Linn. nut extract on thecomponents of immune system in adjuvant arthritis. Vasc. Pharmacol. 42 (2005) 179-186
24. Rasool M., and Varalakshmi P. Suppressive effect of Withania somnifera root powder on MSU crystal-induced Inflammation - an in vivo and in vitro study. Chem-Biol. Interact. 164 3 (2006) 174-180
25. Rasool M., and Varalakshmi P. Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats. Fund. Clin. Pharmacol. 21 2 (2007) 157-164
26. Rasool M., Sabina E.P., and Lavanya B. Anti-inflammatory effect of Spirulina fusiformis on adjuvant-induced arthritis in mice. Biol. Pharm. Bull. 29 1 (2006) 2483-2487
27. Rosenblit P.D., Metzyer R.P., and Wick A.N. Effect of streptozotocin diabetes on acid phosphatase and selected glycosidase activities of serum and various rat organs. Proc. Soc. Exp. Biol. Med. 145 (1974) 244-247
28. Rotruk J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., and Hekstra W.G. Selenium, biochemical role as a component of glutathione peroxidase purification and assay. Science 179 (1973) 588-590
29. Schweyer S., Hemmerlein B., Radzun H.J., and Fayyazi A. Continuous recruitment, co-expression of tumour nerosis factor-alpha and matrix metallo proteinases, and apoptosis of macrophages in gout tophi. Virchows Arch. 437 (2000) 534-539
30. Sinha A.K. Colorimetric assay of catalase. Anal. Biochem. 47 (1972) 389-394
31. Suekawa M., Ishige A., Yusas K., Sudo K., Aburada M., and Hosoya E. Pharmacological studies on ginger. 1. Pharmacological actions of pungent constituents, (6)-gingerol and (6)-shogaol. J. Pharmacobiol. Dyn. 7 (1984) 836-848
32. Suekawa M., Yuasa K., Isono M., and Sone H. Pharmacological studies on ginger IV. Effect of 6-shogaol on the arachidonic cascade. Nippon Yakurigaku Zasshi 88 4 (1986) 263-269
33. Tak H.K., Cooper S.M., and Wilcox W.R. Studies on the nucleation of monosodium urate at 37 degrees C. Arthritis Rheum. 23 (1980) 574-580
34. Terkeltaub R. Pathogenesis and treatment of crystal-induced inflammation. In: Koopman W.J., and Moreland L.W. (Eds). Arthritis and Allied Conditions (2004), Williams and Wilkins, Philadelphia, Lippincott 2357-2372
35. Terkeltaub R.A., and Ginsberg M.H. The inflammatory reaction to crystals. Rheum. Dis. Clin. North Am. 14 (1988) 53-64
36. Thomson M., Al-Qattan K.K., Al-Sawan M., Alnaqeeb M.A., Khan I., and Ali M. The use of trem-ble. Arthritis Rheum. 54 (2002) 383-386
37. Wallingford W.R., and McCarty D.T. Differential membronolytic effects of sodium urate and calcium pyro phosphate dihydrate crystals. J. Exp. Med. 133 (1971) 100
38. Weyand C.M. The role of T cells in RA. Arch. Immun. Ther. Exp. 48 5 (2000) 429-435